Other
13 Authors
- Yu S,
- Hankenson K,
- Jiang D,
- Kwon TG,
- Franceschi RT,
- Fan J,
- Cao H,
- Luo M,
- Patrene K,
- Lai Y,
- Zhang J,
- Roodman GD,
- Xiao G
| First Author | Yu S | Year | 2009 |
| Journal | PLoS One | Volume | 4 |
| Issue | 10 | Pages | e7583 |
| PubMed ID | 19851510 | Mgi Jnum | J:154038 |
| Mgi Id | MGI:4367132 | Doi | 10.1371/journal.pone.0007583 |
| Citation | Yu S, et al. (2009) Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone. PLoS One 4(10):e7583 |
| abstractText | Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its mechanism of action in osteoblast and bone is not well understood. In this study, we show that the anabolic actions of PTH in bone are severely impaired in both growing and adult ovariectomized mice lacking bone-related activating transcription factor 4 (ATF4). Our study demonstrates that ATF4 deficiency suppresses PTH-stimulated osteoblast proliferation and survival and abolishes PTH-induced osteoblast differentiation, which, together, compromise the anabolic response. We further demonstrate that the PTH-dependent increase in osteoblast differentiation is correlated with ATF4-dependent up-regulation of Osterix. This regulation involves interactions of ATF4 with a specific enhancer sequence in the Osterix promoter. Furthermore, actions of PTH on Osterix require this same element and are associated with increased binding of ATF4 to chromatin. Taken together these experiments establish a fundamental role for ATF4 in the anabolic actions of PTH on the skeleton. |
